|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date / Period | Status |
|---|---|---|
| Disorder of kidney due to diabetes mellitus | 08-Sep-2019 | active |
| Chronic kidney disease stage 2 | 08-Sep-2019 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 08-Sep-2019 | active |
| Hyperlipidemia | 24-Jul-2011 | active |
| Chronic sinusitis | 10-Oct-2001 | active |
| Ischemic heart disease | 19-Mar-1989 | active |
| Essential hypertension | 04-Jan-1976 | active |
| Anemia | 31-Dec-1972 | active |
| Acute infective cystitis | 10-Jun-2025 - 13-Jun-2025 | inactive |
| Acute viral pharyngitis | 16-Apr-2017 - 23-Apr-2017 | inactive |
| Polyp of colon | 25-Feb-2016 - 09-May-2017 | inactive |
| Fracture of clavicle | 13-Jun-2015 - 03-Oct-2015 | inactive |
| Fracture of bone | 13-Jun-2015 - 03-Oct-2015 | inactive |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Human isophane insulin 70 unit/mL and recombinant human regular insulin 30 unit/mL solution for injection | 2025-05-17 | - | Inject 10 units subcutaneously once daily | Prediabetes |
| Hydrochlorothiazide 25 mg oral tablet | 2025-05-17 | - | 1 tablet (25 mg) by mouth once daily | Essential hypertension (disorder) |
| Simvastatin 10 mg oral tablet | 2024-10-06 | - | 1 tablet (10 mg) by mouth once daily | Hyperlipidemia |
| Nitroglycerin 400 microgram/actuation sublingual spray | 1989-03-25 | - | 400 micrograms (1 spray) under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes | - |
| Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet | 1989-03-25 | - | 1 tablet (100 mg) once daily | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 17-May-2025 |
| SARS-CoV-2 mRNA vaccine | 20-Feb-2021 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 20-Aug-2016 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Patient evaluation and management | 12-Jun-2025 | - |
| Urine specimen collection | 12-Jun-2025 | - |
| Patient discharge | 12-Jun-2025 | - |
| Taking patient vital signs | 12-Jun-2025 | - |
| Antibiotic therapy | 12-Jun-2025 | - |
| Triage: emergency center | 12-Jun-2025 | - |
| Urinalysis with reflex to microscopy and culture | 12-Jun-2025 | - |
| Pre-discharge assessment | 03-Nov-2019 | - |
| Discharge from hospital | 03-Nov-2019 | - |
| Physical therapy procedure | 02-Nov-2019 | - |
| Nursing care/supplementary surveillance | 02-Nov-2019 | - |
| Speech and language therapy regime | 30-Oct-2019 | - |
| Professional / ancillary services care | 27-Oct-2019 | - |
| History AND physical examination | 26-Oct-2019 | - |
| Initial patient assessment | 26-Oct-2019 | - |
| Development of individualized plan of care | 26-Oct-2019 | - |
Allergies and Intolerances
| No known allergies or intolerances |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Hyperlipidemia clinical management plan | 14-Aug-2011 | Hyperlipidemia (disorder) |
|
||
| Lifestyle education regarding hypertension | 04-Jan-1976 | Essential hypertension (disorder) |
|
||
| Diabetes self management plan | 31-Dec-1972 | Prediabetes (finding) |
|
||
| Immunization Recommendation | Due Date | Reason |
| Influenza virus antigen only vaccine product | 01-Oct-2026 | Annual seasonal influenza vaccination |
Vital Signs
| Vital Signs | 2025-06-12 | 2025-05-17 |
|---|---|---|
| Heart rate | 73.6 /min | 61 /min |
| Respiratory rate | 17.9 /min | 14 /min |
| Oxygen saturation in Arterial blood | 99.5 % | - |
| Body temperature | 37.3 Cel | - |
| Blood pressure panel with all children optional | 82.9 mm[Hg] | 81 mm[Hg] |
| Body Height | - | 180.8 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | - | 0 {score} |
| Body Weight | - | 92 kg |
| Body mass index (BMI) [Ratio] | - | 28.1 kg/m2 |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 12-JUN-2025 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Urine by Test strip | 13.5 | 0 - 20 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test negative | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.005 - 1.030 | {nominal} |
| pH of Urine by Test strip | 6.3 | 5.0 - 8.0 | pH |
| Protein [Mass/volume] in Urine by Test strip | 13.4 | 0 - 20 | mg/dL |
| Nitrite [Presence] in Urine by Test strip | Urine nitrite positive | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = + | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test | ||
| Leukocytes [#/area] in Urine sediment by Microscopy high power field | 47.8 H | 0 - 5 | /[HPF] |
| Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 1.1 | 0 - 5 | /[HPF] |
| Epithelial cells [#/area] in Urine sediment by Microscopy high power field | 1.1 | 0 - 5 | /[HPF] |
| Casts [Presence] in Urine sediment by Light microscopy | Urine microscopy: no casts | ||
| Mucus [Presence] in Urine sediment by Light microscopy | Mucus in urine | ||
| Bacteria [#/area] in Urine sediment by Microscopy high power field | Finding of presence of bacteria | ||
| Bacteria identified in Urine by Culture |
Device Use
| Device | Date (since) |
|---|---|
| Home nebulizer (physical object) | 10-Oct-2001 |
| Blood glucose meter (physical object) | 30-Dec-1972 |